Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
1 hedge funds and large institutions have $0 invested in Allied Healthcare Products in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.
91% less funds holding
Funds holding: 11 → 1 (-10)
100% less capital invested
Capital invested by funds: $114K → $0 (-$114K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$39K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$20K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$15.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.87K |
AHPI Hedge Fund Activity: Q1 2023 in Review
1 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q1 2023, worth a combined $0 — down 100% from $114K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AHPI and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $6.38K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $39K sold.
- 1 institutional investor held Allied Healthcare Products (AHPI) as of Q1 2023, down from 11 in Q4 2022.
- Funds reported $0 of Allied Healthcare Products stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Allied Healthcare Products positions in Q1 2023 and 10 closed out, a net change of -10 holders.
- The largest Allied Healthcare Products buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $6.38K added.
- The largest Allied Healthcare Products seller in Q1 2023 was Renaissance Technologies, an estimated $39K sold.
Based on aggregated 13F filings for Q1 2023.